Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Terumo Corporation

TRUMYPNK
Healthcare
Medical - Instruments & Supplies
$12.90
$0.17(1.34%)
U.S. Market opens in 1h 36m

Terumo Corporation Fundamental Analysis

Terumo Corporation (TRUMY) shows moderate financial fundamentals with a PE ratio of 23.59, profit margin of 11.68%, and ROE of 9.06%. The company generates $1105.6B in annual revenue with strong year-over-year growth of 12.40%.

Key Strengths

Cash Position1252.57%
PEG Ratio-0.07
Current Ratio1.51

Areas of Concern

ROE9.06%
We analyze TRUMY's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 70.1/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.

Fundamental Health Score

B
70.1/100

We analyze TRUMY's fundamental strength across five key dimensions:

Efficiency Score

Weak

TRUMY struggles to generate sufficient returns from assets.

ROA > 10%
5.72%

Valuation Score

Excellent

TRUMY trades at attractive valuation levels.

PE < 25
23.59
PEG Ratio < 2
-0.07

Growth Score

Excellent

TRUMY delivers strong and consistent growth momentum.

Revenue Growth > 5%
12.40%
EPS Growth > 10%
10.50%

Financial Health Score

Excellent

TRUMY maintains a strong and stable balance sheet.

Debt/Equity < 1
0.26
Current Ratio > 1
1.51

Profitability Score

Weak

TRUMY struggles to sustain strong margins.

ROE > 15%
9.06%
Net Margin ≥ 15%
11.68%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is TRUMY Expensive or Cheap?

P/E Ratio

TRUMY trades at 23.59 times earnings. This indicates a fair valuation.

23.59

PEG Ratio

When adjusting for growth, TRUMY's PEG of -0.07 indicates potential undervaluation.

-0.07

Price to Book

The market values Terumo Corporation at 2.00 times its book value. This may indicate undervaluation.

2.00

EV/EBITDA

Enterprise value stands at 10.09 times EBITDA. This signals the market has high growth expectations.

10.09

How Well Does TRUMY Make Money?

Net Profit Margin

For every $100 in sales, Terumo Corporation keeps $11.68 as profit after all expenses.

11.68%

Operating Margin

Core operations generate 16.17 in profit for every $100 in revenue, before interest and taxes.

16.17%

ROE

Management delivers $9.06 in profit for every $100 of shareholder equity.

9.06%

ROA

Terumo Corporation generates $5.72 in profit for every $100 in assets, demonstrating efficient asset deployment.

5.72%

Following the Money - Real Cash Generation

Operating Cash Flow

Terumo Corporation produces operating cash flow of $211.25B, showing steady but balanced cash generation.

$211.25B

Free Cash Flow

Terumo Corporation generates strong free cash flow of $134.72B, providing ample flexibility for dividends, buybacks, or growth.

$134.72B

FCF Per Share

Each share generates $91.33 in free cash annually.

$91.33

FCF Yield

TRUMY converts 4.42% of its market value into free cash.

4.42%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

23.59

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.07

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.00

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.75

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.26

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.51

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.09

vs 25 benchmark

ROA

Return on assets percentage

0.06

vs 25 benchmark

ROCE

Return on capital employed

0.10

vs 25 benchmark

How TRUMY Stacks Against Its Sector Peers

MetricTRUMY ValueSector AveragePerformance
P/E Ratio23.5928.25 Better (Cheaper)
ROE9.06%780.00% Weak
Net Margin11.68%-20122.00% (disorted) Strong
Debt/Equity0.260.30 Neutral
Current Ratio1.514.66 Neutral
ROA5.72%-14687.00% (disorted) Weak

TRUMY outperforms its industry in 2 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Terumo Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

66.42%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

38.66%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

81.25%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ